Interestingly, the cytoskeletal protein SM22α reduces aortic aneurysm formation through the ROS/NF-κB pathway [43], indicating CRP2 and SM22α may control AAA formation via different signaling pathways. The gene discussed is NFKB1; the disease is triple-A syndrome.